Storage pool disease in chronic lymphocytic leukemia: Abnormal aggregation and secretion without bleeding

American Journal of the Medical Sciences

Volumn 313, Issue 3, 1997, Pages 176-181

  Carr Jr , Marcus E ^a,b,c   Hines, Susan ^a,b,c   Carr, Sheryl L ^a,b   Todd, William M ^a,c   Taylor, Tamarro L ^a,b   Mohanty, Laxmi ^a,c  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Platelet aggregation; Platelet force development; Platelet secretion

Indexed keywords

ADENOSINE TRIPHOSPHATE; FIBRINOGEN; RISTOCETIN;

ADULT; ARTICLE; BLEEDING; BLEEDING TIME; CASE REPORT; CHRONIC LYMPHATIC LEUKEMIA; ELECTRON MICROSCOPY; HUMAN; MALE; THROMBOCYTE AGGREGATION; THROMBOCYTE RELEASE REACTION; THROMBOCYTE STRUCTURE; THROMBOCYTOPENIA;

EID: 0343471554     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-199703000-00009     Document Type: Article

References (31)

1. Mateo J, Martino R, Borrell M, Gari M, Casas F, Font- cuberta J. Acquired factor VIII inhibitor preceding chronic lymphocytic leukemia. Ann Hematol. 1993;67:309-11.
2. Brownlee RE Jr, Shockley WW. Acquired von Willebrand's syndrome. Therapeutic and diagnostic implications. Arch Otolaryngol Head Neck Surg. 1991;117:106-8.
3. Rubinstein DB, Longo DL. Peripheral destruction of platelets in chronic lymphocytic leukemia: recognition, prognosis and therapeutic implications. Am J Med. 1981;71:729-32.
4. Garvey MB, Freedman J. Indirect platelet radioactive antiglobulin test in patients with lymphoproliferative disease. J Lab Clin Med. 1986;107:123-8.
5. De Rossi G, Granati L, Girelli G, Gandolfo G, Arista MC, Martelli M, et al. Incidence and prognostic significance of autoantibodies against erythrocytes and platelets in chronic lymphocytic leukemia (CLL). Nouv Rev Fr Hematol. 1988;30:403-6.
6. Oldham RK, Larson SM, Givelber HM, Chretien PB, Johnson RE. A preliminary study of 51 Cr-labeled platelets for evaluation of splenic sequestration in chronic lymphocytic leukemia. J Nucl Med. 1973;14:219-22.
7. Nieuwenhuis HK, Akkerman JWN, Sixma JJ. Patients with a prolonged bleeding time and normal aggregation tests may have storage pool deficiency: studies on one hundred six patients. Blood. 1987;70:620-3.
8. Logan LJ, Rapaport SI, Maher I. Albinism and abnormal platelet function. N Engl J Med. 1971;284:1340-5.
9. Weiss HJ, Rogers J. Thrombocytopathia due to abnormalities in platelet release reaction-studies on six unrelated patients. Blood. 1972:39:187-96.
10. Pareti FI, Day HJ, Mills DCB. Nucleotide and serotonin metabolism in platelets with defective secondary aggregation. Blood. 1974;44:789-800.
11. Carr ME, Zekert SL. Abnormal clot retraction, altered fibrin structure and normal platelet function in multiple myeloma. Am J Physiol. 1994;266:H1195-1201.
12. Carr ME, Zekert SL. Measurement of platelet mediated force development during plasma clot formation. Am J Med Sci 1991;302:13-8.
13. Carr ME. Measurement of platelet force: the Hemodyne Hemostatic Analyzer. Clinical Laboratory Management Review. 1995;9:312-9.
14. Matsuda J, Saitoh N, Gotoh M, Kawasugi K, Gohchi K, Tsukamoto M. Phosphatidyl serine-dependent anti-prothrombin antibody is exclusive to patients with lupus anticoagulant. Br J Rheumatol. 1996;35:589-91.
15. Clauss A. A rapid physiological coagulation method for determination of fibrinogen. Acta Haematol. 1957;17:237-46.
16. Uchiyama S, Bach ML, Didisheim P, Bowie EJ. Clinical evaluation of a new test of hemostasis: the filter bleeding time. Thromb Res. 1984;34:397-405.
17. Weiss HJ, Willis AL, Kuhn D, Brand H. Prostaglandin E2 potentintion of platelet aggregation induced by LASS endoperoxide: absent in storage pool disease, normal after aspirin ingestion. Brit J Haematol. 1976;32:257-72.
18. McNicol A, Israels SJ, Robertson C, Gerrard JM. The empty sack syndrome: a platelet storage pool deficiency associated with empty dense granules. Brit J Haematol. 1994;86:574-82.
19. Apitz-Castro R, Cruz MR, Ledezma E, Merino F, Ramirez-Duque P, Dangelmeier C, et al. The storage pool deficiency in platelets from humans with the Chediak-Higaushi syndrome: study of six patients. Brit J Haematol. 1985;59:471-83.
20. Green D, Ts'ao CH, Cohen I, Rossi EC. Haemorrhagic thrombocytopnthy associated with dilatation of the plateletmembrane complex. Brit J Haematol. 1981;48:595-600.
21. Kubisz P, Suranova J. A new abnormality of platelet functions. Association of storage pool disease (thrombocytopathia A) with impaired reactivity of platelets to collagen. Folia Haematologica-Internationales Magazin fur Klinische und Morphologische Blutforschung. 1975;102:346-56.
22. DePinho RA, Kaplan KL. The Hermansky-Pudlak syndrome. Report of three cases and review of pathophysiology and management considerations. Medicine. 1985;64:192-202.
23. D'Angelo G, Calano D, Giardini C. Blood platelet changes in myeloproliferative disorders. Minerva Med. 1988;79:853-7.
24. Remaley AT, Kennedy JM, Paposata M. Evaluation of the clinical utility of platelet aggregation studies. Am J Hematol. 1989;31:188-93.
25. Rodgers RPC, Levin L. A critical reappraisal of the bleeding time. Semin Thromb Hemost. 1990;16:1-20.
26. Carr ME, Carr SL, Hantgan RR, Braaten J. Glycoprotein IIb/IIIa blockade inhibits platelet-mediated force development and reduces gel elastic modulus. Thromb Haemost. 1995;73:499-505.
27. Carr ME, Carr SL. Fibrin structure and concentration alter clot elastic modulus but do not alter platelet mediated force development. Blood Coagul Fibrinolysis. 1995;6:79-86.
28. De Clerck F, Borgers M, de Gaetano G, Vermylen J. Dissociation of clot retraction from platelet granule fusion and degranulation: an ultrastructural study of Reptilase-human platelet-rich plasma clots. Brit J Haematol. 1975;29:341-8.
29. Carr ME, Zekert SL, Marston AW, Magruder C, Kirschbaum B. Comparison of platelet force development, a new measure of platelet function, and bleeding time in chronic hemodialysis patients (abstract). Am J Clin Path. 1994;101:392.
30. Greilich PE, Carr ME, Zekert SL, Dent RM. Quantitative assessment of platelet function and clot structure in patients with severe coronary artery disease. Am J Med Sci. 1994;307:15-20.
31. Greilich PE, Carr ME, Carr SL, Chang AS. Reductions in platelet force development by cardiopulmonary bypass are associated with hemorrhage. Anesth Anal. 1995;80:459-65.